| Literature DB >> 33762529 |
Yousra Nashaat1, Hadil Sabry2, Soha Ahmed Hassan3.
Abstract
OBJECTIVE: The aim of this study is to compare the cytotoxicity of triple antibiotic paste (TAP) with an antiinflammatory drug (TAP+Catafast-TAPC) in nano and regular formulations versus calcium hydroxide as intracanal medicaments.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33762529 PMCID: PMC8056808 DOI: 10.14744/eej.2020.29292
Source DB: PubMed Journal: Eur Endod J ISSN: 2548-0839
Material specification, composition and manufacturer
| Material | Specification | Composition | Manufacturer |
|---|---|---|---|
| Metapex (Control group) | Non-setting calcium hydroxide with iodoform | Calcium hydroxide, iodoform and silicon oil. | META BIOMED Co, Chungbuk, Korea. |
| Triple antibiotic paste (TAP) | Mixture of ciprofloxacin, metronidazole and minocycline. | Using commercially available tablets of Ciprofloxacin (Ciprofloxacin 500 mg), Metronidazole (Flagyl 500 mg) and Minocycline (Minocin 50 mg). Following the removal of the enteric coating of the tablets, the contents were ground using a mortar and pestle and mixed in an equal amounts by weight (1:1:1) in a mixing pad (100 mg of each) and then will be dissolved in 100 mL of sterile water to prepare 1 mg/mL solution of TAP in a creamy consistency | Flagyl 500 mg: (Sanofi Aventis, Cairo, Egypt) |
| Catafast | 50 mg NSAIDs granules for oral solution (Diclofenac potassium) | Every sachet contains 50 mg diclofenac potassium, Potassium hydrogen carbonate, mannitol; aspartame, saccharin sodium, glyceryl dibehenate, mint flavor, anise flavor. | NOVARTIS PHARMA S.A.E., Cairo, Egypt |
| Nano Triple antibiotic paste (TAP) | Mixture of nano form of ciprofloxacin, metronidazole and minocycline. | Nano TAPC consists of TAPC: Ciprofloxacin (Ciprofloxacin 500 mg), Metronidazole (Flagyl 500 mg) and Minocycline (Minocin 50 mg), mixed in equal amounts by weight (1:1:1) 100 mg of each, together with the 50 mg Catafast granules. This mixture was transferred into nano structure material using Top-down technique through the combination of various processes including fine grinding, sonication homogenisation and ultrafiltration to prevent agglomeration. Ball milling was used to produce nanomaterials by mechanical attrition in which kinetic energy from a grinding medium was transferred to material undergoing reduction. Nanomaterials were put back together with compaction and consolidation in an industrial scale process to form materials with enhanced properties (13). |
Figure 1(a) Transmission electron microscope micrograph (TEM) of TAP nanoparticles with scale bar is 0.5 µm. (b) Transmission electron microscope micrograph (TEM) of TAP nanoparticles with scale bar 1µm. (c) Scanning electron microscope micrograph (SEM) of TAP nanoparticles with scale bar1µm. (d) Scanning electron micrograph (SEM) of TAP nanoparticles with scale bar 1µm
Figure 2Graph showing the inhibitory concentration (IC50) values of all tested intra canal medicaments after 24 hours
Cytotoxicity test results measured by % of viable cells of all groups at different time intervals for (Conc. 10mg/ml)
| (Conc. 10 mg/ml) | % Viability | P value | ||
|---|---|---|---|---|
| 24 h | 48 h | 7 days | ||
| TAPC | 27.98Aa | 26.40Aa | 22.93Ab | 0.305 ns |
| Nano TAPC | 24.14Aa | 22.93Ba | 19.92Ca | 0.018 |
| Ca(OH)2 | 20.40Ab | 19.19Ab | 17.82Ac | 0.079 ns |
| P value | <0.001 | <0.001 | 0.027 | |
Signifiant (P<0.05), ns: non-significant (P>0.05). Different capital letters mean statistical significance in rows. Different small letters mean statistical significance in columns
Cytotoxicity test results measured by % of viable cells of all groups at different time intervals for (Conc. 0.07mg/ml)
| (Conc. 0.07 mg/ml) | % Viability | P value | ||
|---|---|---|---|---|
| 24 h | 48 h | 7 days | ||
| TAPC | 91.65Ab | 86.77Bb | 85.62Cb | 0.002 |
| Nano TAPC | 84.52Ab | 83.43Aa | 78.49Ab | 0.138ns |
| Ca(OH)2 | 69.82Ac | 63.24Bc | 57.21Cc | <0.001 |
| P value | <0.001 | <0.001 | <0.001 | |
Significant (P<0.05), ns: non-significant (P>0.05). Different capital letters mean statistical significance in rows. Different small letters mean statistical significance in columns
Figure 3Line graph showing the mean values of % viability (± SD) of all groups at different time intervals for (Conc. 10mg/ml)
Figure 5Line graph showing the mean values of % viability (±SD) of all groups at different time intervals for (Conc. 0.07 mg/ml)
Percentage of apoptotic and necrotic cells in cultures assessed by using flow cytometry analysis for different intracanal medicaments
| Variables | Early apoptosis | Late apoptosis | Necrosis |
|---|---|---|---|
| TAPC | 2.35±0.070 | 3.17±0.098 | 1.61±0.104 |
| Nano TAPC | 7.23±0.104 | 3.65±0.128 | 2.14±0.087 |
| Ca(OH)2 | 5.91±0.268 | 13.26±0.854 | 3.28±0.072 |
| P value | <0.001 | <0.001 | <0.001 |
Significant from control group (P<0.05), ns; non-significant from control group
Figure 6(a-c) The dot plots are representative of control and human fibroblast cells exposed to various intra canal medicaments, representing the populations of viable cells [bottom left: annexin V–, propidium iodide (PI–)], early apoptotic (bottom right: annexin V+, PI– ), late apoptotic (top right: annexin V+, PI+), and necrotic (top left: PI+) cells. The x-axis is the fluorescence intensity of annexin-V; the y-axis is the fluorescence intensity of PI
Comparison of flowcytometry test results (Mean values± SDs) between TAPC and Nano TAPC experimental groups
| Variables | Early apoptosis | Late apoptosis | Necrosis |
|---|---|---|---|
| TAPC | 2.350.070a | 3.170.098a | 1.610.104a |
| Nano TAPC | 7.230.104b | 3.650.128b | 2.140.087b |
| P value | <0.001 | 0.006 | 0.003 |
Significant (P<0.05), ns: non-significant (P>0.05) Different small letters mean statistical significance in column
Figure 7Bar chart showing flowcytometry early, late apoptosis and necrosis values of TAPC and Nano TAPC
Cytotoxicity test results measured by % of viable cells of all groups at different time intervals for (Conc. 0.625mg/ml)
| (Conc. 0.625 mg/ml) | % Viability | P value | ||
|---|---|---|---|---|
| 24 h | 48 h | 7 days | ||
| TAPC | 85.16Ab | 81.87Aa | 67.62Ab | 0.365ns |
| Nano TAPC | 74.20Ac | 59.39Ba | 56.65Ca | <0.001 |
| Ca(OH)2 | 54.83Aa | 52.91Bb | 48.40Cc | 0.004 |
| P value | <0.001 | <0.001 | <0.001 | |
Significant (P<0.05), ns: non-significant (P>0.05). Different capital letters mean statistical significance in rows. Different small letters mean statistical significance in columns